These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 12841076)

  • 21. Is three a crowd or company?: Behind-the-counter drugs.
    Barth AS
    Food Drug Law J; 2008; 63(4):865-89. PubMed ID: 19601386
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA considers effects of managed care marketplace on drug promotional practices.
    Wechsler J
    Formulary; 1995 Dec; 30(12):840-1. PubMed ID: 10153083
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescribing practices of physicians affiliated with multiple formularies.
    Haymes A; Dietze D
    AAPPO J; 1991; 1(5):9-14. PubMed ID: 10149639
    [No Abstract]   [Full Text] [Related]  

  • 25. OTCs: the wild card in cost effectiveness.
    McCarthy R
    Bus Health; 1999 Apr; 17(4):33-5. PubMed ID: 10351245
    [No Abstract]   [Full Text] [Related]  

  • 26. Canadians spending more on drugs.
    Eggertson L
    CMAJ; 2005 May; 172(10):1279. PubMed ID: 15883396
    [No Abstract]   [Full Text] [Related]  

  • 27. Health plans tackle medical savings accounts.
    Coleman D
    Healthplan; 1997; 38(3):92-8. PubMed ID: 10176869
    [No Abstract]   [Full Text] [Related]  

  • 28. Rx-to-OTC shift: not for these widely used drugs.
    Chase SL
    RN; 1995 Jan; 58(1):67. PubMed ID: 7624708
    [No Abstract]   [Full Text] [Related]  

  • 29. Providing health economic data to managed care.
    Navarro RP
    Manag Care Interface; 1998 Sep; 11(9):62-3, 66. PubMed ID: 10187588
    [No Abstract]   [Full Text] [Related]  

  • 30. Report of the Task Force on the future of OTC drugs.
    Collins DE
    Food Drug Law J; 2000; 55(1):27-31. PubMed ID: 12269359
    [No Abstract]   [Full Text] [Related]  

  • 31. Rx drugs switched to OTC.
    FDA Drug Bull; 1983 Nov; 13(3):29-30. PubMed ID: 6653955
    [No Abstract]   [Full Text] [Related]  

  • 32. Rx vs OTC? Damned if you do,..
    Guglielmo WJ
    Med Econ; 2006 Mar; 83(6):33-4. PubMed ID: 16619787
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA considers OTC drug labeling reform.
    Am Pharm; 1995 Nov; NS35(11):5-6. PubMed ID: 8533722
    [No Abstract]   [Full Text] [Related]  

  • 34. If patients question your Rx.
    Guglielmo WJ
    Med Econ; 2003 Nov; 80(21):90-1. PubMed ID: 14666874
    [No Abstract]   [Full Text] [Related]  

  • 35. Prescriptions enter the political arena.
    Regier H
    J Leg Med (N Y); 1974; 2(2):24-30. PubMed ID: 4545342
    [No Abstract]   [Full Text] [Related]  

  • 36. Increasing stakes and complex dynamics in the formulary process.
    Tadlock C
    Manag Care Interface; 2007 Mar; 20(3):12, 14. PubMed ID: 17458473
    [No Abstract]   [Full Text] [Related]  

  • 37. Steps taken to lessen tampering with OTC drugs.
    FDA Drug Bull; 1983 Apr; 13(1):6. PubMed ID: 6852409
    [No Abstract]   [Full Text] [Related]  

  • 38. OTC switch considered for asthma.
    Am Pharm; 1995 Jan; NS35(1):10. PubMed ID: 7887368
    [No Abstract]   [Full Text] [Related]  

  • 39. Prescription to over-the-counter drug switches.
    Rheinstein PH
    Am Fam Physician; 1997 Sep; 56(4):1211-4. PubMed ID: 9310067
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of the new Thai drug bill.
    Phaosavasdi S; Taneepanichskul S; Tannirandorn Y; Karnjanapitak A; Pruksapong C; Kullavanijaya P
    J Med Assoc Thai; 2003 Feb; 86(2):191-4. PubMed ID: 12678159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.